Learn the complete step-by-step process for FDA generic drug approval via the ANDA pathway, including bioequivalence, CMC requirements, and GDUFA timelines.
View MoreExplore the differences between generic and brand name drugs, focusing on FDA labeling, therapeutic equivalence, and how to save on medication costs safely.
View MoreBioequivalence for inhalers, patches, and injections ensures generic drugs work as well as brand-name versions. Unlike pills, these systems require complex testing to prove they deliver medicine correctly to the lungs, skin, or bloodstream.
View MoreGeneric drugs save up to 85% on medication costs and are just as effective as brand-name versions for most people. Learn when generics work, when to be cautious, and how to avoid hidden risks with NTI drugs.
View MorePharmacists verify generic equivalence using the FDA's Orange Book to ensure safe, legal substitutions. Learn how pharmaceutical, bioequivalence, and therapeutic equivalence standards protect patients and save billions annually.
View More